Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10417761rdf:typepubmed:Citationlld:pubmed
pubmed-article:10417761lifeskim:mentionsumls-concept:C1123023lld:lifeskim
pubmed-article:10417761lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:10417761lifeskim:mentionsumls-concept:C0022173lld:lifeskim
pubmed-article:10417761lifeskim:mentionsumls-concept:C0205307lld:lifeskim
pubmed-article:10417761lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:10417761lifeskim:mentionsumls-concept:C1709160lld:lifeskim
pubmed-article:10417761lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:10417761lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:10417761pubmed:issue5lld:pubmed
pubmed-article:10417761pubmed:dateCreated1999-8-13lld:pubmed
pubmed-article:10417761pubmed:abstractTextExpression of prostaglandin-H-synthase (PGHS) isozymes was analyzed in 50 biopsies of normal human skin and of pre-malignant and malignant skin lesions, by means of quantitative RT-PCR, immunoprecipitation and Western blotting, as well as immunohistochemistry. Normal skin constitutively expressed PGHS-1 in all cell layers of the epidermis, in endothelial cells of small blood vessels and in sweat-gland epithelium. PGHS-2 expression was very low and restricted to a few keratinocytes of the interfollicular and follicular epidermis. Steady-state concentrations of PGHS-1 and PGHS-2 mRNA were similar in normal skin and in basal-cell carcinomas, but PGHS-1 mRNA was reduced and PGHS-2 mRNA was elevated in actinic keratoses, squamous-cell carcinomas and keratoacanthomas. PGHS-1 protein was detected in all tumor biopsies, being occasionally increased in basal-cell carcinomas. High amounts of PGHS-2 protein were found in actinic keratoses, squamous-cell carcinomas and keratoacanthomas, but not in basal-cell carcinomas. Four malignant melanomas included in this study contained PGHS-1 but no PGHS-2 protein. Immunohistochemical analysis of the biopsies identified keratinocytes, in addition to cells of inflammatory infiltrates and of dendritic morphology, as the major PGHS-expressing cell types. PGHS-2-specific signals were spread throughout the epidermal part of actinic keratoses and squamous-cell carcinomas. These data suggest that constitutive up-regulation of PGHS-2 expression is a consistent pre-malignant event in squamous-cell cancer development in man, as it is in animal models of skin carcinogenesis. Thus, pre-cancerous lesions such as actinic keratoses present a likely target for chemoprevention of skin cancer by selective PGHS-2 inhibitors.lld:pubmed
pubmed-article:10417761pubmed:languageenglld:pubmed
pubmed-article:10417761pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10417761pubmed:citationSubsetIMlld:pubmed
pubmed-article:10417761pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10417761pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10417761pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10417761pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10417761pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10417761pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10417761pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10417761pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10417761pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10417761pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10417761pubmed:statusMEDLINElld:pubmed
pubmed-article:10417761pubmed:monthAuglld:pubmed
pubmed-article:10417761pubmed:issn0020-7136lld:pubmed
pubmed-article:10417761pubmed:authorpubmed-author:ZimmermannRRlld:pubmed
pubmed-article:10417761pubmed:authorpubmed-author:HeiseHHlld:pubmed
pubmed-article:10417761pubmed:authorpubmed-author:MarksFFlld:pubmed
pubmed-article:10417761pubmed:authorpubmed-author:Fürstenberger...lld:pubmed
pubmed-article:10417761pubmed:authorpubmed-author:KriegPPlld:pubmed
pubmed-article:10417761pubmed:authorpubmed-author:BayerlCClld:pubmed
pubmed-article:10417761pubmed:authorpubmed-author:Müller-Decker...lld:pubmed
pubmed-article:10417761pubmed:authorpubmed-author:ReinerthGGlld:pubmed
pubmed-article:10417761pubmed:copyrightInfoCopyright 1999 Wiley-Liss, Inc.lld:pubmed
pubmed-article:10417761pubmed:issnTypePrintlld:pubmed
pubmed-article:10417761pubmed:day27lld:pubmed
pubmed-article:10417761pubmed:volume82lld:pubmed
pubmed-article:10417761pubmed:ownerNLMlld:pubmed
pubmed-article:10417761pubmed:authorsCompleteYlld:pubmed
pubmed-article:10417761pubmed:pagination648-56lld:pubmed
pubmed-article:10417761pubmed:dateRevised2007-7-24lld:pubmed
pubmed-article:10417761pubmed:meshHeadingpubmed-meshheading:10417761...lld:pubmed
pubmed-article:10417761pubmed:meshHeadingpubmed-meshheading:10417761...lld:pubmed
pubmed-article:10417761pubmed:meshHeadingpubmed-meshheading:10417761...lld:pubmed
pubmed-article:10417761pubmed:meshHeadingpubmed-meshheading:10417761...lld:pubmed
pubmed-article:10417761pubmed:meshHeadingpubmed-meshheading:10417761...lld:pubmed
pubmed-article:10417761pubmed:meshHeadingpubmed-meshheading:10417761...lld:pubmed
pubmed-article:10417761pubmed:meshHeadingpubmed-meshheading:10417761...lld:pubmed
pubmed-article:10417761pubmed:meshHeadingpubmed-meshheading:10417761...lld:pubmed
pubmed-article:10417761pubmed:meshHeadingpubmed-meshheading:10417761...lld:pubmed
pubmed-article:10417761pubmed:meshHeadingpubmed-meshheading:10417761...lld:pubmed
pubmed-article:10417761pubmed:meshHeadingpubmed-meshheading:10417761...lld:pubmed
pubmed-article:10417761pubmed:meshHeadingpubmed-meshheading:10417761...lld:pubmed
pubmed-article:10417761pubmed:meshHeadingpubmed-meshheading:10417761...lld:pubmed
pubmed-article:10417761pubmed:meshHeadingpubmed-meshheading:10417761...lld:pubmed
pubmed-article:10417761pubmed:year1999lld:pubmed
pubmed-article:10417761pubmed:articleTitleProstaglandin-H-synthase isozyme expression in normal and neoplastic human skin.lld:pubmed
pubmed-article:10417761pubmed:affiliationResearch Program, Tumor Cell Regulation, Deutsches Krebsforschungszentrum, Heidelberg, Germany. K.Mueller-Decker@DKFZ-Heidelberg.delld:pubmed
pubmed-article:10417761pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10417761pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10417761lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10417761lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10417761lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10417761lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10417761lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10417761lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10417761lld:pubmed